Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 7/28/2025

Chlamydia Infection Management

Clinical Manifestations

  • Chlamydia infection can cause urethritis in men and cervicitis in women, often presenting as discharge or dysuria with mild or absent symptoms, affecting both men and women 1
  • Proctitis can occur in men who engage in receptive anal intercourse, causing rectal discharge and pain during defecation 1
  • Reactive arthritis, including Reiter's syndrome, can occur in both men and women as a result of chlamydia infection, although the exact mechanism is not fully established 1
  • Conjunctivitis and pharyngeal infection are other possible manifestations of chlamydia infection, although the latter is not established as a cause of pharyngitis 1
  • Chlamydia trachomatis infections in men can cause urethritis, epididymitis, and proctitis 2, 3
  • Urethritis is the most common manifestation in men, often with mild or absent symptoms, while epididymitis accounts for approximately 50% of outpatient visits for this condition among young men 1
  • Chlamydia trachomatis infection can cause significant reproductive complications in women, including pelvic inflammatory disease (PID), salpingitis, endometritis, perihepatitis (Fitz-Hugh-Curtis syndrome), and urethral syndrome 1

Risk Factors and Diagnosis

  • Risk factors for chlamydia infection include age (women under 25 years), ethnicity (African-American and Hispanic populations), marital status (unmarried), and sexual behavior (new or multiple sexual partners) 3, 4, 5
  • Nucleic acid amplification tests (NAATs) are the most sensitive and specific tests for diagnosing chlamydia infection, and first-void urine samples can be used for testing in men 5, 6, 1
  • The American College of Physicians and other guideline societies recommend prompt testing and treatment to prevent potential complications, as supported by the CDC and USPSTF 2, 6
  • The American College of Obstetricians and Gynecologists (ACOG) recommends screening all pregnant women under 25 years of age and those with new or multiple sex partners, ideally during both the first prenatal visit and the third trimester 7

Treatment Recommendations

  • The Centers for Disease Control and Prevention (CDC) recommends azithromycin 1g orally in a single dose or doxycycline 100mg orally twice a day for 7 days as treatment options for chlamydia infection 8, 6
  • Alternative treatment options include erythromycin base 500mg orally four times a day for 7 days, erythromycin ethylsuccinate 800mg orally four times a day for 7 days, and ofloxacin 300mg orally twice a day for 7 days, although efficacy and compliance may vary 8
  • Treatment regimens for chlamydia include:

    | Treatment Regimen | Dosage | Duration | | --- | --- | --- | | Azithromycin | 1g orally in a single dose | - | | Doxycycline | 100mg orally twice daily | 7 days | | Erythromycin base (for pregnant women) | 500 mg orally four times a day | 7 days | | Amoxicillin (for pregnant women) | 500 mg orally three times a day | 7 days | | Erythromycin base (alternative for pregnant women) | 250 mg orally four times a day | 14 days | | Azithromycin (alternative for pregnant women) | 1 g orally in a single dose | - | 6, 9, 8

Prevention and Control

  • Partner notification and treatment is essential, with all sexual partners from the past 60 days being evaluated and treated to prevent reinfection 8, 6
  • Abstinence from sexual intercourse is recommended until 7 days after single-dose therapy, completion of 7-day regimen, or until all sex partners are treated, to reduce transmission risk 8
  • Medications should be dispensed on site when possible, with the first dose directly observed to maximize compliance, particularly in populations with poor compliance 8
  • Consistent condom use reduces transmission risk, and regular screening for high-risk individuals is recommended to prevent complications associated with chlamydia infection, although specific guidelines may vary depending on the population and risk factors 8, 6
  • Retesting approximately 3 months after treatment is recommended to prevent reinfection 6

Complications and Long-term Effects

  • Chlamydia infection can cause low libido and erectile dysfunction through both direct and indirect mechanisms, including psychological impact of diagnosis, inflammation, and complications of untreated infection 5
  • Epididymitis, a potential complication of chlamydia, if severe and left untreated, could potentially affect testicular function 6
  • Early detection and treatment of chlamydia infection is the most effective approach to preventing associated sexual dysfunction and other complications, with regular screening recommended for those at high risk 6
  • The American College of Physicians and other medical organizations emphasize the importance of addressing psychological factors that may persist after treatment, evaluating for complications, and considering referral to sexual health specialists if dysfunction persists after successful treatment 6